
Amy E. Juedes
Examiner (ID: 8010, Phone: (571)272-4471 , Office: P/1644 )
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1644 |
| Total Applications | 1273 |
| Issued Applications | 443 |
| Pending Applications | 154 |
| Abandoned Applications | 706 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6527924
[patent_doc_number] => 20100015112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'Methods for the Induction of Professional and Cytokine-Producing Regulatory T Cells'
[patent_app_type] => utility
[patent_app_number] => 12/502122
[patent_app_country] => US
[patent_app_date] => 2009-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 10170
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20100015112.pdf
[firstpage_image] =>[orig_patent_app_number] => 12502122
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/502122 | Methods for the Induction of Professional and Cytokine-Producing Regulatory T Cells | Jul 12, 2009 | Abandoned |
Array
(
[id] => 5464419
[patent_doc_number] => 20090324619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'Immunogenic Protein Carrier Containing An Antigen Presenting Cell Binding Domain and A Cysteine-Rich Domain'
[patent_app_type] => utility
[patent_app_number] => 12/491521
[patent_app_country] => US
[patent_app_date] => 2009-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4269
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20090324619.pdf
[firstpage_image] =>[orig_patent_app_number] => 12491521
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/491521 | Immunogenic protein carrier containing an antigen presenting cell binding domain and a cysteine-rich domain | Jun 24, 2009 | Issued |
Array
(
[id] => 7573096
[patent_doc_number] => 20110268752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-03
[patent_title] => 'Inducible Regulatory T-Cell Generation for Hematopoietic Transplants'
[patent_app_type] => utility
[patent_app_number] => 12/999926
[patent_app_country] => US
[patent_app_date] => 2009-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 19634
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0268/20110268752.pdf
[firstpage_image] =>[orig_patent_app_number] => 12999926
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/999926 | Inducible regulatory T-cell generation for hematopoietic transplants | Jun 18, 2009 | Issued |
Array
(
[id] => 6314006
[patent_doc_number] => 20100111916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'Materials and Method of Modulating the Immune Response'
[patent_app_type] => utility
[patent_app_number] => 12/486189
[patent_app_country] => US
[patent_app_date] => 2009-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 40126
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20100111916.pdf
[firstpage_image] =>[orig_patent_app_number] => 12486189
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/486189 | Materials and Method of Modulating the Immune Response | Jun 16, 2009 | Abandoned |
Array
(
[id] => 5569359
[patent_doc_number] => 20090252737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-08
[patent_title] => 'T Cell Regulatory Genes And Methods Of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/485765
[patent_app_country] => US
[patent_app_date] => 2009-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 24654
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20090252737.pdf
[firstpage_image] =>[orig_patent_app_number] => 12485765
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/485765 | T Cell Regulatory Genes And Methods Of Use Thereof | Jun 15, 2009 | Abandoned |
Array
(
[id] => 5398294
[patent_doc_number] => 20090318357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'Molecules Preferentially Associated with Effector T Cells or Regulatory T Cells and Methods of Their Use'
[patent_app_type] => utility
[patent_app_number] => 12/483826
[patent_app_country] => US
[patent_app_date] => 2009-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 31046
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318357.pdf
[firstpage_image] =>[orig_patent_app_number] => 12483826
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/483826 | Molecules Preferentially Associated with Effector T Cells or Regulatory T Cells and Methods of Their Use | Jun 11, 2009 | Abandoned |
Array
(
[id] => 6125326
[patent_doc_number] => 20110086011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-14
[patent_title] => 'Prevention or Treatment of Immune-Relevant Disease by Modification of Microfloral Populations'
[patent_app_type] => utility
[patent_app_number] => 12/993909
[patent_app_country] => US
[patent_app_date] => 2009-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10943
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20110086011.pdf
[firstpage_image] =>[orig_patent_app_number] => 12993909
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/993909 | Prevention or treatment of immune-relevant disease by modification of microfloral populations | Jun 2, 2009 | Issued |
Array
(
[id] => 7754638
[patent_doc_number] => 20120027776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'DIABETIC MODEL'
[patent_app_type] => utility
[patent_app_number] => 12/475704
[patent_app_country] => US
[patent_app_date] => 2009-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10291
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20120027776.pdf
[firstpage_image] =>[orig_patent_app_number] => 12475704
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/475704 | DIABETIC MODEL | May 31, 2009 | Abandoned |
Array
(
[id] => 6030872
[patent_doc_number] => 20110081313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-07
[patent_title] => 'MECHANISM OF ACTION OF PRIMARY CELL DERIVED BIOLOGIC'
[patent_app_type] => utility
[patent_app_number] => 12/995054
[patent_app_country] => US
[patent_app_date] => 2009-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10643
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20110081313.pdf
[firstpage_image] =>[orig_patent_app_number] => 12995054
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/995054 | MECHANISM OF ACTION OF PRIMARY CELL DERIVED BIOLOGIC | May 28, 2009 | Abandoned |
Array
(
[id] => 5958516
[patent_doc_number] => 20110182903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'NOVEL SOLUBLE CD83 POLYPEPTIDES, FORMULATIONS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/736887
[patent_app_country] => US
[patent_app_date] => 2009-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 23773
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20110182903.pdf
[firstpage_image] =>[orig_patent_app_number] => 12736887
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/736887 | NOVEL SOLUBLE CD83 POLYPEPTIDES, FORMULATIONS AND METHODS OF USE | May 21, 2009 | Abandoned |
Array
(
[id] => 5551803
[patent_doc_number] => 20090285789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'METHODS FOR ENHANCING INNATE AND ADAPTIVE IMMUNITY AND ANTIGEN IMMUNOGENICITY'
[patent_app_type] => utility
[patent_app_number] => 12/467126
[patent_app_country] => US
[patent_app_date] => 2009-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4713
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20090285789.pdf
[firstpage_image] =>[orig_patent_app_number] => 12467126
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/467126 | METHODS FOR ENHANCING INNATE AND ADAPTIVE IMMUNITY AND ANTIGEN IMMUNOGENICITY | May 14, 2009 | Abandoned |
Array
(
[id] => 9401520
[patent_doc_number] => 08691572
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-08
[patent_title] => 'Diagnosing, monitoring and treating inflammation'
[patent_app_type] => utility
[patent_app_number] => 12/464037
[patent_app_country] => US
[patent_app_date] => 2009-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 53
[patent_no_of_words] => 15099
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12464037
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/464037 | Diagnosing, monitoring and treating inflammation | May 10, 2009 | Issued |
Array
(
[id] => 7697092
[patent_doc_number] => 20110229498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE'
[patent_app_type] => utility
[patent_app_number] => 12/991654
[patent_app_country] => US
[patent_app_date] => 2009-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19171
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20110229498.pdf
[firstpage_image] =>[orig_patent_app_number] => 12991654
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/991654 | COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE | May 7, 2009 | Abandoned |
Array
(
[id] => 6601150
[patent_doc_number] => 20100098704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)'
[patent_app_type] => utility
[patent_app_number] => 12/387654
[patent_app_country] => US
[patent_app_date] => 2009-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 29772
[patent_no_of_claims] => 97
[patent_no_of_ind_claims] => 79
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20100098704.pdf
[firstpage_image] =>[orig_patent_app_number] => 12387654
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/387654 | Antibodies that bind human dendritic and epithelial cell 205 (DEC-205) | May 4, 2009 | Issued |
Array
(
[id] => 6054501
[patent_doc_number] => 20110110861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'Methods of Detecting Cells with a Disrupted Cell Membrane, Cells Infected with A Pathogen, Dying Cells or Dead Cells'
[patent_app_type] => utility
[patent_app_number] => 12/989947
[patent_app_country] => US
[patent_app_date] => 2009-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 31480
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20110110861.pdf
[firstpage_image] =>[orig_patent_app_number] => 12989947
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/989947 | Methods of Detecting Cells with a Disrupted Cell Membrane, Cells Infected with A Pathogen, Dying Cells or Dead Cells | Apr 30, 2009 | Abandoned |
Array
(
[id] => 5464357
[patent_doc_number] => 20090324557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'METHOD TO INDUCE AND EXPAND THERAPEUTIC ALLOANTIGEN-SPECIFIC HUMAN REGULATORY T CELLS IN LARGE-SCALE'
[patent_app_type] => utility
[patent_app_number] => 12/432964
[patent_app_country] => US
[patent_app_date] => 2009-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9195
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20090324557.pdf
[firstpage_image] =>[orig_patent_app_number] => 12432964
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/432964 | Method to induce and expand therapeutic alloantigen-specific human regulatory T cells in large-scale | Apr 29, 2009 | Issued |
Array
(
[id] => 5457836
[patent_doc_number] => 20090257988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'METHODS AND COMPOSITIONS FOR ACCELERATING THE GENERATION OF REGULATORY T CELLS EX VIVO'
[patent_app_type] => utility
[patent_app_number] => 12/421941
[patent_app_country] => US
[patent_app_date] => 2009-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14186
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20090257988.pdf
[firstpage_image] =>[orig_patent_app_number] => 12421941
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/421941 | METHODS AND COMPOSITIONS FOR ACCELERATING THE GENERATION OF REGULATORY T CELLS EX VIVO | Apr 9, 2009 | Abandoned |
Array
(
[id] => 5457861
[patent_doc_number] => 20090258013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/420234
[patent_app_country] => US
[patent_app_date] => 2009-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 60
[patent_no_of_words] => 54558
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258013.pdf
[firstpage_image] =>[orig_patent_app_number] => 12420234
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/420234 | NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES | Apr 7, 2009 | Abandoned |
Array
(
[id] => 5484920
[patent_doc_number] => 20090274685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'ILT3 POLYPEPTIDES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/419824
[patent_app_country] => US
[patent_app_date] => 2009-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 15289
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20090274685.pdf
[firstpage_image] =>[orig_patent_app_number] => 12419824
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/419824 | ILT3 polypeptides and uses thereof | Apr 6, 2009 | Issued |
Array
(
[id] => 5302827
[patent_doc_number] => 20090297479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'DC-HIL CONJUGATES FOR TREATMENT OF T-CELL DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/411898
[patent_app_country] => US
[patent_app_date] => 2009-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 39011
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20090297479.pdf
[firstpage_image] =>[orig_patent_app_number] => 12411898
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/411898 | DC-HIL CONJUGATES FOR TREATMENT OF T-CELL DISORDERS | Mar 25, 2009 | Abandoned |